Osteomyelitis and Septic Arthritis in the Darwin Prospective Melioidosis Study
2024

Osteomyelitis and Septic Arthritis in Melioidosis Patients

Sample size: 115 publication Evidence: moderate

Author Information

Author(s): Stuart Campbell, Dane Hicks, Rajendra P. Shetty, Bart J. Currie

Primary Institution: Royal Darwin Hospital, Menzies School of Health Research

Hypothesis

What are the epidemiology, presentation, treatment, and outcomes of osteomyelitis and septic arthritis in melioidosis patients?

Conclusion

The study found that with proper treatment, outcomes for osteoarticular melioidosis can be good, but many regions lack the necessary resources, leading to high mortality.

Supporting Evidence

  • 10.8% of patients with melioidosis had osteomyelitis or septic arthritis.
  • 69.6% of patients had diabetes mellitus as a risk factor.
  • 61.7% of patients underwent operative management.
  • 7% of patients died from melioidosis during the study.

Takeaway

This study looked at how some people get bone and joint infections from a germ called melioidosis, and it showed that with the right medicine and surgery, they can get better.

Methodology

Data was collected from the Darwin Prospective Melioidosis Study database for patients diagnosed with osteomyelitis or septic arthritis over 24 years.

Potential Biases

Potential biases due to retrospective data collection and evolving treatment protocols.

Limitations

The study's retrospective nature and changes in management over 24 years may affect the results.

Participant Demographics

Of the 115 patients, 51.3% were male, with a mean age of 48.7 years, and 70.4% were Aboriginal and/or Torres Strait Islander.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/ofid/ofae741

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication